QQ客服 官方微博 反馈留言

	The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China
	Huang, Kewu; Guo, Yanfei; Kang, Jian; An, Li; Zheng, Zeguang; Ma, Lijun; Peng, Liping; Wang, Hongyang; Su, Rong; Itoh, Yohji
	2019
卷号	13
关键词	antimuscarinic budesonide COPD formoterol glucocorticoid methylxanthine
ISSN号	1753-4658
DOI	10.1177/1753466619853500
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6337491
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Huang, Kewu,Guo, Yanfei,Kang, Jian,et al. The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China[J],2019,13.
APA	Huang, Kewu.,Guo, Yanfei.,Kang, Jian.,An, Li.,Zheng, Zeguang.,...&Wang, Chen.(2019).The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China.,13.
MLA	Huang, Kewu,et al."The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China".13(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。